Blockchain Registration Transaction Record

Clene Showcases CNM-Au8(R) at Investor Conferences

Clene (NASDAQ: CLNN) presents CNM-Au8(R) at investor conferences, showcasing its potential for treating neurodegenerative diseases. Learn more about Clene's participation and the development of CNM-Au8(R).

Clene Showcases CNM-Au8(R) at Investor Conferences

This news matters as it highlights the participation of Clene in important investor conferences, providing insight into the development of CNM-Au8(R) and its potential impact on treating neurodegenerative diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xbd9bc7b470c2b721a768d195a48135f7cbd9e4d62052911baf3a7157bfa978ec
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintcornFcws-a47c75c5089d925698a99bb555134876